X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS UNICHEM LAB DR. DATSONS LABS/
UNICHEM LAB
 
P/E (TTM) x -10.9 -66.6 - View Chart
P/BV x 0.2 0.7 21.8% View Chart
Dividend Yield % 0.0 2.3 -  

Financials

 DR. DATSONS LABS   UNICHEM LAB
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
UNICHEM LAB
Mar-18
DR. DATSONS LABS/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs126382 32.9%   
Low Rs31234 13.2%   
Sales per share (Unadj.) Rs133.0116.3 114.4%  
Earnings per share (Unadj.) Rs0.2-18.9 -0.8%  
Cash flow per share (Unadj.) Rs6.6-11.7 -56.3%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %01.6 0.0%  
Book value per share (Unadj.) Rs128.8381.0 33.8%  
Shares outstanding (eoy) m31.6670.34 45.0%   
Bonus/Rights/Conversions FCCBBB-  
Price / Sales ratio x0.62.6 22.2%   
Avg P/E ratio x516.1-16.3 -3,170.2%  
P/CF ratio (eoy) x11.8-26.2 -45.1%  
Price / Book Value ratio x0.60.8 75.1%  
Dividend payout %0-26.4 0.0%   
Avg Mkt Cap Rs m2,47721,668 11.4%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m562,006 2.8%   
Avg. sales/employee Rs ThNM3,587.8-  
Avg. wages/employee Rs ThNM880.0-  
Avg. net profit/employee Rs ThNM-583.7-  
INCOME DATA
Net Sales Rs m4,2118,180 51.5%  
Other income Rs m79610 12.9%   
Total revenues Rs m4,2898,790 48.8%   
Gross profit Rs m569-1,320 -43.1%  
Depreciation Rs m204505 40.5%   
Interest Rs m43080 537.1%   
Profit before tax Rs m13-1,295 -1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-2 81.8%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m633 18.3%   
Profit after tax Rs m5-1,331 -0.4%  
Gross profit margin %13.5-16.1 -83.7%  
Effective tax rate %48.0-2.6 -1,861.6%   
Net profit margin %0.1-16.3 -0.7%  
BALANCE SHEET DATA
Current assets Rs m6,85223,318 29.4%   
Current liabilities Rs m6,7114,635 144.8%   
Net working cap to sales %3.3228.4 1.5%  
Current ratio x1.05.0 20.3%  
Inventory Days Days161122 132.1%  
Debtors Days Days318121 262.2%  
Net fixed assets Rs m3,6738,163 45.0%   
Share capital Rs m317141 225.0%   
"Free" reserves Rs m3,76126,660 14.1%   
Net worth Rs m4,07826,801 15.2%   
Long term debt Rs m1,6713 50,630.3%   
Total assets Rs m12,63331,890 39.6%  
Interest coverage x1.0-15.2 -6.8%   
Debt to equity ratio x0.40 332,785.4%  
Sales to assets ratio x0.30.3 129.9%   
Return on assets %3.4-3.9 -87.8%  
Return on equity %0.1-5.0 -2.4%  
Return on capital %7.7-4.5 -169.0%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9644,356 22.1%   
Fx outflow Rs m6070-   
Net fx Rs m3574,356 8.2%   
CASH FLOW
From Operations Rs m1,345-1,123 -119.7%  
From Investments Rs m-2,25616,487 -13.7%  
From Financial Activity Rs m-1,200-8,811 13.6%  
Net Cashflow Rs m-2,1116,552 -32.2%  

Share Holding

Indian Promoters % 4.5 50.1 9.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.1 -  
FIIs % 1.4 3.0 45.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 31.7 296.8%  
Shareholders   20,807 20,176 103.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   STERLING BIOTECH  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  PFIZER  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS